Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment.
[typhoid]
No
access
to
safe
water
is
an
important
risk
factor
for
typhoid
fever
,
yet
risk-level
heterogeneity
is
unaccounted
for
in
previous
global
burden
estimates
.
Since
WHO
has
recommended
risk-based
use
of
typhoid
polysaccharide
vaccine
,
we
revisited
the
burden
of
typhoid
fever
in
low
-income
and
middle
-income
countries
(
LMICs
)
after
adjusting
for
water-related
risk
.
We
estimated
the
typhoid
disease
burden
from
studies
done
in
LMICs
based
on
blood
-culture-confirmed
incidence
rates
applied
to
the
2010
population
,
after
correcting
for
operational
issues
related
to
surveillance
,
limitations
of
diagnostic
tests
,
and
water-related
risk
.
We
derived
incidence
estimates
,
correction
factors
,
and
mortality
estimates
from
systematic
literature
reviews
.
We
did
scenario
analyses
for
risk
factors
,
diagnostic
sensitivity
,
and
case
fatality
rates
,
accounting
for
the
uncertainty
in
these
estimates
and
we
compared
them
with
previous
disease
burden
estimates
.
The
estimated
number
of
typhoid
fever
cases
in
LMICs
in
2010
after
adjusting
for
water-related
risk
was
11
·
9
million
(
95
%
CI
9
·
9
-
14
·
7
)
cases
with
129
 
000
(
75
 
000
-
208
 
000
)
deaths
.
By
comparison
,
the
estimated
risk-unadjusted
burden
was
20
·
6
million
(
17
·
5
-
24
·
2
)
cases
and
223
 
000
(
131
 
000
-
344
 
000
)
deaths
.
Scenario
analyses
indicated
that
the
risk-
factor
adjustment
and
updated
diagnostic
test
correction
factor
derived
from
systematic
literature
reviews
were
the
drivers
of
differences
between
the
current
estimate
and
past
estimates
.
The
risk-adjusted
typhoid
fever
burden
estimate
was
more
conservative
than
previous
estimates
.
However
,
by
distinguishing
the
risk
differences
,
it
will
allow
assessment
of
the
effect
at
the
population
level
and
will
facilitate
cost-effectiveness
calculations
for
risk-based
vaccination
strategies
for
future
typhoid
conjugate
vaccine
.
Bill
and
Melinda
Gates
Foundation
.
Diseases
Validation
Diseases presenting
"fever"
symptom
22q11.2 deletion syndrome
acute rheumatic fever
alexander disease
allergic bronchopulmonary aspergillosis
canavan disease
carcinoma of the gallbladder
child syndrome
congenital toxoplasmosis
cushing syndrome
cystinuria
dracunculiasis
erdheim-chester disease
esophageal adenocarcinoma
esophageal carcinoma
familial mediterranean fever
focal myositis
hodgkin lymphoma, classical
lamellar ichthyosis
legionellosis
locked-in syndrome
malignant atrophic papulosis
neonatal adrenoleukodystrophy
neuralgic amyotrophy
oculocutaneous albinism
papillon-lefèvre syndrome
pyomyositis
pyruvate dehydrogenase deficiency
scrub typhus
severe combined immunodeficiency
sneddon syndrome
systemic capillary leak syndrome
triple a syndrome
typhoid
waldenström macroglobulinemia
wolf-hirschhorn syndrome
This symptom has already been validated